At the 43-month endpoint, a total of 60.7% (307/506) of the abaloparatide followed by alendronate group had ≥3% increase in bone mass at all 3 sites (P<0.0001) vs. 24% (121/505) of the placebo followed by alendronate group.
To investigate the potential association between male gynecomastia and essential oils, study authors from the National Institute of Environmental Health Sciences analyzed 8 common components included in lavender and tea tree oils.
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
Metformin treatment during pregnancy may improve outcomes in women with polycystic ovary syndrome.
Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.
Study assessed cardiovascular function, quality of life, and mental/physical health in overt and cured Cushing syndrome.
Oral micronized progesterone may diminish hot flushes and night sweats in perimenopausal women, according to research presented at ENDO 2018.
Results comparing the prevalence of obesity amongst adolescents with the rate of bariatric surgeries were presented at ENDO 2018.
A new birth control pill for men appears to be safe when used daily for a month, with hormone responses consistent with effective contraception.
Research findings indicate improved glycemic outcomes in children with T1D using the MiniMed 670G system, similar to those observed for adolescents and adults.
